{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:11:40Z","timestamp":1793815900294,"version":"4.6.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02780-y","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T09:50:56Z","timestamp":1748685056000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Tenascin-C drives cardiovascular dysfunction in a mouse model of diabetic cardiomyopathy"],"prefix":"10.1186","volume":"24","author":[{"given":"Zsuzsanna","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Dostal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra Lujza","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Aykac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel Antunes","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silva Laura","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simge","family":"Baydar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnab\u00e1s","family":"V\u00e1radi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy L.","family":"Nadasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Szekeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars H.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Zins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Hallstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bilban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"\u00c1gg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazha","family":"Hamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Ferdinandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Paneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno K.","family":"Podesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"key":"2780_CR1","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas. Diabetes Res Clin Pract. 2019;157:107843.","journal-title":"Diabetes Res Clin Pract"},{"key":"2780_CR2","unstructured":"WHO: Cause-specific mortality, 2000\u20132019. In.; 2020."},{"issue":"2","key":"2780_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2047487319878371","volume":"26","author":"E Dal Canto","year":"2019","unstructured":"Dal Canto E, Ceriello A, Ryd\u00e9n L, Ferrini M, Hansen TB, Schnell O, Standl E, Beulens JW. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26(2):25\u201332.","journal-title":"Eur J Prev Cardiol"},{"issue":"19","key":"2780_CR4","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA. 1979;241(19):2035\u20138.","journal-title":"JAMA"},{"issue":"6","key":"2780_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595\u2013602.","journal-title":"Am J Cardiol"},{"issue":"19","key":"2780_CR6","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","volume":"101","author":"RB Devereux","year":"2000","unstructured":"Devereux RB, Roman MJ, Paranicas M, O\u2019Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation. 2000;101(19):2271\u20136.","journal-title":"Circulation"},{"issue":"3","key":"2780_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2337\/diacare.27.3.699","volume":"27","author":"AG Bertoni","year":"2004","unstructured":"Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care. 2004;27(3):699\u2013703.","journal-title":"Diabetes Care"},{"issue":"9","key":"2780_CR8","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.2337\/diacare.24.9.1614","volume":"24","author":"GA Nichols","year":"2001","unstructured":"Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care. 2001;24(9):1614\u20139.","journal-title":"Diabetes Care"},{"issue":"4","key":"2780_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1210\/er.2003-0012","volume":"25","author":"ZY Fang","year":"2004","unstructured":"Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004;25(4):543\u201367.","journal-title":"Endocr Rev"},{"issue":"9","key":"2780_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17(9):585\u2013607.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"2780_CR11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624\u201338.","journal-title":"Circ Res"},{"issue":"25","key":"2780_CR12","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115(25):3213\u201323.","journal-title":"Circulation"},{"key":"2780_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","volume":"18","author":"T Miki","year":"2013","unstructured":"Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev. 2013;18:149\u201366.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"2780_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","volume":"125","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis NG. The extracellular matrix in ischemic and nonischemic heart failure. Circ Res. 2019;125(1):117\u201346.","journal-title":"Circ Res"},{"issue":"4","key":"2780_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jacc.2005.09.050","volume":"47","author":"J Asbun","year":"2006","unstructured":"Asbun J, Villarreal FJ. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol. 2006;47(4):693\u2013700.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2780_CR16","doi-asserted-by":"publisher","first-page":"166044","DOI":"10.1016\/j.bbadis.2020.166044","volume":"1867","author":"I Tuleta","year":"2021","unstructured":"Tuleta I, Frangogiannis NG. Diabetic fibrosis. BBA Mol Basis Dis. 2021;1867(4):166044.","journal-title":"BBA Mol Basis Dis."},{"issue":"4","key":"2780_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.5937\/jomb0-24662","volume":"39","author":"M Vasanthi","year":"2020","unstructured":"Vasanthi M, Adole PS, Pandit VR, Vinod KV. Assessment of serum tenascin-C and growth differentiation factor-15 among type 2 diabetes mellitus patients with and without acute coronary syndrome. J Med Biochem. 2020;39(4):460.","journal-title":"J Med Biochem."},{"key":"2780_CR18","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00125-020-05108-5","volume":"63","author":"B Gellen","year":"2020","unstructured":"Gellen B, Thorin-Trescases N, Thorin E, Gand E, Sosner P, Brishoual S, Rigalleau V, Montaigne D, Javaugue V, Pucheu Y. Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort. Diabetologia. 2020;63:915\u201323.","journal-title":"Diabetologia"},{"issue":"9","key":"2780_CR19","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1097\/HJH.0000000000002097","volume":"37","author":"IF Gon\u00e7alves","year":"2019","unstructured":"Gon\u00e7alves IF, Acar E, Costantino S, Szabo PL, Hamza O, Tretter EV, Klein KU, Trojanek S, Abraham D, Paneni F. Epigenetic modulation of tenascin C in the heart: Implications on myocardial ischemia, hypertrophy and metabolism. J Hypertens. 2019;37(9):1861\u201370.","journal-title":"J Hypertens"},{"issue":"5","key":"2780_CR20","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1002\/ehf2.12794","volume":"7","author":"D Santer","year":"2020","unstructured":"Santer D, Nagel F, Gon\u00e7alves IF, Kaun C, Wojta J, Fagyas M, Kr\u0161\u0161\u00e1k M, Balogh \u00c1, Papp Z, T\u00f3th A. Tenascin-C aggravates ventricular dilatation and angiotensin-converting enzyme activity after myocardial infarction in mice. ESC Heart Failure. 2020;7(5):2113\u201322.","journal-title":"ESC Heart Failure"},{"issue":"4","key":"2780_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/ejhf.464","volume":"18","author":"T Yokokawa","year":"2016","unstructured":"Yokokawa T, Sugano Y, Nakayama T, Nagai T, Matsuyama TA, Ohta-Ogo K, Ikeda Y, Ishibashi-Ueda H, Nakatani T, Yasuda S. Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy. Eur J Heart Fail. 2016;18(4):375\u201385.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2780_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0092-8674(86)90374-0","volume":"47","author":"R Chiquet-Ehrismann","year":"1986","unstructured":"Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 1986;47(1):131\u20139.","journal-title":"Cell"},{"issue":"10","key":"2780_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/bies.950171009","volume":"17","author":"R Chiquet-Ehrismann","year":"1995","unstructured":"Chiquet-Ehrismann R, Hagios C, Schenk S. The complexity in regulating the expression of tenascins. BioEssays. 1995;17(10):873\u20138.","journal-title":"BioEssays"},{"issue":"23","key":"2780_CR24","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1242\/jcs.190546","volume":"129","author":"KS Midwood","year":"2016","unstructured":"Midwood KS, Chiquet M, Tucker RP, Orend G. Tenascin-C at a glance. J Cell Sci. 2016;129(23):4321\u20137.","journal-title":"J Cell Sci"},{"issue":"11","key":"2780_CR25","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1253\/circj.CJ-12-1033","volume":"76","author":"K Imanaka-Yoshida","year":"2012","unstructured":"Imanaka-Yoshida K. Tenascin-C in cardiovascular tissue remodeling-from development to inflammation and repair\u2013. Circ J. 2012;76(11):2513\u201320.","journal-title":"Circ J"},{"issue":"5","key":"2780_CR26","doi-asserted-by":"publisher","first-page":"C781","DOI":"10.1152\/ajpcell.00353.2020","volume":"319","author":"K Imanaka-Yoshida","year":"2020","unstructured":"Imanaka-Yoshida K, Tawara I, Yoshida T. Tenascin-C in cardiac disease: a sophisticated controller of inflammation, repair, and fibrosis. Am J Physiol Cell Physiol. 2020;319(5):C781\u201396.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2780_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12079-009-0075-1","volume":"3","author":"KS Midwood","year":"2009","unstructured":"Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal. 2009;3:287\u2013310.","journal-title":"J Cell Commun Signal."},{"issue":"7","key":"2780_CR28","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/labinvest.3780313","volume":"81","author":"K Imanaka-Yoshida","year":"2001","unstructured":"Imanaka-Yoshida K, Hiroe M, Nishikawa T, Ishiyama S, Shimojo T, Ohta Y, Sakakura T, Yoshida T. Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab Invest. 2001;81(7):1015\u201324.","journal-title":"Lab Invest"},{"issue":"1","key":"2780_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0002-9440(10)62954-9","volume":"167","author":"M Tamaoki","year":"2005","unstructured":"Tamaoki M, Imanaka-Yoshida K, Yokoyama K, Nishioka T, Inada H, Hiroe M, Sakakura T, Yoshida T. Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol. 2005;167(1):71\u201380.","journal-title":"Am J Pathol"},{"issue":"4","key":"2780_CR30","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/HJH.0000000000001628","volume":"36","author":"BK Podesser","year":"2018","unstructured":"Podesser BK, Kreibich M, Dzilic E, Santer D, F\u00f6rster L, Trojanek S, Abraham D, Kr\u0161\u0161\u00e1k M, Klein KU, Tretter EV. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis. J Hypertens. 2018;36(4):847\u201356.","journal-title":"J Hypertens"},{"key":"2780_CR31","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2401006","author":"A Kiss","year":"2023","unstructured":"Kiss A, Nadasy GL, Fees A, Arnold Z, Aykac I, Dostal C, Szab\u00f3 GT, Szab\u00f3 PL, Szekeres M, Pokreisz P. Alterations in coronary resistance artery network geometry in diabetes and the role of tenascin C. Rev Cardiovasc Med. 2023. https:\/\/doi.org\/10.31083\/j.rcm2401006.","journal-title":"Rev Cardiovasc Med"},{"issue":"5","key":"2780_CR32","first-page":"1237","volume":"152","author":"N Nakao","year":"1998","unstructured":"Nakao N, Hiraiwa N, Yoshiki A, Ike F, Kusakabe M. Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. Am J Pathol. 1998;152(5):1237.","journal-title":"Am J Pathol"},{"issue":"6","key":"2780_CR33","first-page":"1071","volume":"40","author":"A Matsuda","year":"1999","unstructured":"Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M. Corneal wound healing in tenascin knockout mouse. Invest Ophthalmol Vis Sci. 1999;40(6):1071\u201380.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"22","key":"2780_CR34","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1242\/jcs.112.22.3847","volume":"112","author":"EJ Mackie","year":"1999","unstructured":"Mackie EJ, Tucker RP. The tenascin-C knockout revisited. J Cell Sci. 1999;112(22):3847\u201353.","journal-title":"J Cell Sci"},{"issue":"10","key":"2780_CR35","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1101\/gad.6.10.1821","volume":"6","author":"Y Saga","year":"1992","unstructured":"Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S. Mice develop normally without tenascin. Genes Dev. 1992;6(10):1821\u201331.","journal-title":"Genes Dev"},{"issue":"4","key":"2780_CR36","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1002\/cpz1.78","volume":"1","author":"BL Furman","year":"2021","unstructured":"Furman BL. Streptozotocin-induced diabetic models in mice and rats. Current protocols. 2021;1(4):e78.","journal-title":"Current protocols"},{"issue":"19","key":"2780_CR37","doi-asserted-by":"publisher","first-page":"e030478","DOI":"10.1161\/JAHA.123.030478","volume":"12","author":"C Bueno-Beti","year":"2023","unstructured":"Bueno-Beti C, Lim CX, Protonotarios A, Szabo PL, Westaby J, Mazic M, Sheppard MN, Behr E, Hamza O, Kiss A. An mTORC1-dependent mouse model for cardiac sarcoidosis. J Am Heart Assoc. 2023;12(19):e030478.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2780_CR38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/01.CIR.0000155257.33485.6D","volume":"111","author":"A Borb\u00e9ly","year":"2005","unstructured":"Borb\u00e9ly A, Van Der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ, Paulus WJ. Cardiomyocyte stiffness in diastolic heart failure. Circulation. 2005;111(6):774\u201381.","journal-title":"Circulation"},{"issue":"4","key":"2780_CR39","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCRESAHA.111.300105","volume":"112","author":"N Hamdani","year":"2013","unstructured":"Hamdani N, Krysiak J, Kreusser MM, Neef S, Dos Remedios CG, Maier LS, Kr\u00fcger M, Backs J, Linke WA. Crucial role for Ca2+\/calmodulin-dependent protein kinase-II in regulating diastolic stress of normal and failing hearts via titin phosphorylation. Circ Res. 2013;112(4):664\u201374.","journal-title":"Circ Res"},{"issue":"1","key":"2780_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00395-022-00946-3","volume":"117","author":"A Kiss","year":"2022","unstructured":"Kiss A, Wu P, Schlederer M, Pilz PM, Szabo PL, Li J, Weber L, Vraka C, Pichler V, Mitterhauser M. Sympathetic nerve innervation and metabolism in ischemic myocardium in response to remote ischemic perconditioning. Basic Res Cardiol. 2022;117(1):42.","journal-title":"Basic Res Cardiol"},{"key":"2780_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mce.2015.01.012","volume":"403","author":"M Szekeres","year":"2015","unstructured":"Szekeres M, N\u00e1dasy GL, Turu G, Solt\u00e9sz-Katona E, Beny\u00f3 Z, Offermanns S, Ruisanchez \u00c9, Szab\u00f3 E, Tak\u00e1ts Z, B\u00e1tkai S. Endocannabinoid-mediated modulation of Gq\/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension. Mol Cell Endocrinol. 2015;403:46\u201356.","journal-title":"Mol Cell Endocrinol"},{"issue":"22","key":"2780_CR42","doi-asserted-by":"publisher","first-page":"16429","DOI":"10.3390\/ijms242216429","volume":"24","author":"B B\u00e1nyai","year":"2023","unstructured":"B\u00e1nyai B, Vass Z, Kiss S, Balogh A, Brandhuber D, Karvaly G, Kov\u00e1cs K, N\u00e1dasy GL, Hunyady L, D\u00f6rnyei G. Role of CB1 cannabinoid receptors in vascular responses and vascular remodeling of the aorta in female mice. Int J Mol Sci. 2023;24(22):16429.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2780_CR43","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3390\/ijms22042023","volume":"22","author":"M Perera-Gonzalez","year":"2021","unstructured":"Perera-Gonzalez M, Kiss A, Kaiser P, Holzweber M, Nagel F, Watzinger S, Acar E, Szabo PL, Gon\u00e7alves IF, Weber L. The role of tenascin C in cardiac reverse remodeling following banding-debanding of the ascending aorta. Int J Mol Sci. 2021;22(4):2023.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2780_CR44","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","volume":"119","author":"M Ackers-Johnson","year":"2016","unstructured":"Ackers-Johnson M, Li PY, Holmes AP, O\u2019Brien S-M, Pavlovic D, Foo RS. A simplified, Langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart. Circ Res. 2016;119(8):909\u201320.","journal-title":"Circ Res"},{"issue":"9","key":"2780_CR45","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.2337\/db17-0294","volume":"66","author":"S Costantino","year":"2017","unstructured":"Costantino S, Paneni F, Battista R, Castello L, Capretti G, Chiandotto S, Tanese L, Russo G, Pitocco D, Lanza GA. Impact of glycemic variability on chromatin remodeling, oxidative stress, and endothelial dysfunction in patients with type 2 diabetes and with target HbA1c levels. Diabetes. 2017;66(9):2472\u201382.","journal-title":"Diabetes"},{"issue":"4","key":"2780_CR46","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cardfail.2016.06.008","volume":"23","author":"UL Fax\u00e9n","year":"2017","unstructured":"Fax\u00e9n UL, Hage C, Benson L, Zabarovskaja S, Andreasson A, Donal E, Daubert J-C, Linde C, Brismar K, Lund LH. HFpEF and HFrEF display different phenotypes as assessed by IGF-1 and IGFBP-1. J Cardiac Fail. 2017;23(4):293\u2013303.","journal-title":"J Cardiac Fail"},{"issue":"1","key":"2780_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cvr\/cvr183","volume":"92","author":"J Golledge","year":"2011","unstructured":"Golledge J, Clancy P, Maguire J, Lincz L, Koblar S. The role of tenascin C in cardiovascular disease. Cardiovasc Res. 2011;92(1):19\u201328.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"2780_CR48","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.jacc.2006.03.033","volume":"47","author":"A Sato","year":"2006","unstructured":"Sato A, Aonuma K, Imanaka-Yoshida K, Yoshida T, Isobe M, Kawase D, Kinoshita N, Yazaki Y, Hiroe M. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol. 2006;47(11):2319\u201325.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2780_CR49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ehf2.12039","volume":"2","author":"D Santer","year":"2015","unstructured":"Santer D, Nagel F, Kreibich M, Dzilic E, Moser PT, Muschitz G, Inci M, Krssak M, Plasenzotti R, Bergmeister H. In vivo and ex vivo functional characterization of left ventricular remodelling after myocardial infarction in mice. ESC heart failure. 2015;2(3):171\u20137.","journal-title":"ESC heart failure"},{"issue":"11","key":"2780_CR50","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/eurjhf\/hfp128","volume":"11","author":"M Franz","year":"2009","unstructured":"Franz M, Berndt A, Altendorf-Hofmann A, Fiedler N, Richter P, Schumm J, Fritzenwanger M, Figulla HR, Brehm BR. Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy. Eur J Heart Fail. 2009;11(11):1057\u201362.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2780_CR51","first-page":"2009724","volume":"2022","author":"M Li","year":"2022","unstructured":"Li M, Wu M, Zhu H, Hua Y, Ma Z, Yao J, Feng B, Shi B. Serum tenascin-C and alarin levels are associated with cardiovascular diseases in type 2 diabetes mellitus. Int J Endocrinol. 2022;2022(1):2009724.","journal-title":"Int J Endocrinol."},{"issue":"24","key":"2780_CR52","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.21037\/atm-2020-116","volume":"8","author":"S Yonebayashi","year":"2020","unstructured":"Yonebayashi S, Tajiri K, Li S, Sato A. Tenascin-C: an emerging prognostic biomarker in diabetes. Ann Transl Med. 2020;8(24):1699.","journal-title":"Ann Transl Med."},{"issue":"3","key":"2780_CR53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1253\/circj.71.327","volume":"71","author":"F Terasaki","year":"2007","unstructured":"Terasaki F, Okamoto H, Onishi K, Sato A, Shimomura H, Tsukada B, Imanaka-Yoshida K, Hiroe M, Yoshida T, Kitaura Y. Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy. Circ J. 2007;71(3):327\u201330.","journal-title":"Circ J"},{"issue":"6","key":"2780_CR54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.cardfail.2012.02.009","volume":"18","author":"A Sato","year":"2012","unstructured":"Sato A, Hiroe M, Akiyama D, Hikita H, Nozato T, Hoshi T, Kimura T, Wang Z, Sakai S, Imanaka-Yoshida K. Prognostic value of serum tenascin-C levels on long-term outcome after acute myocardial infarction. J Cardiac Fail. 2012;18(6):480\u20136.","journal-title":"J Cardiac Fail"},{"issue":"7","key":"2780_CR55","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.humpath.2008.12.017","volume":"40","author":"B Tsukada","year":"2009","unstructured":"Tsukada B, Terasaki F, Shimomura H, Otsuka K, Otsuka K, Katashima T, Fujita S, Imanaka-Yoshida K, Yoshida T, Hiroe M. High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation. Hum Pathol. 2009;40(7):1015\u201322.","journal-title":"Hum Pathol"},{"key":"2780_CR56","first-page":"436","volume":"22","author":"Y Kobayashi","year":"2016","unstructured":"Kobayashi Y, Yoshida S, Zhou Y, Nakama T, Ishikawa K, Arima M, Nakao S, Sassa Y, Takeda A, Hisatomi T. Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy. Mol Vis. 2016;22:436.","journal-title":"Mol Vis"},{"issue":"8","key":"2780_CR57","first-page":"2758","volume":"43","author":"R Castellon","year":"2002","unstructured":"Castellon R, Caballero S, Hamdi HK, Atilano SR, Aoki AM, Tarnuzzer RW, Kenney MC, Grant MB, Ljubimov AV. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture. Invest Ophthalmol Vis Sci. 2002;43(8):2758\u201366.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2780_CR58","doi-asserted-by":"publisher","first-page":"620541","DOI":"10.3389\/fimmu.2021.620541","volume":"12","author":"S Yonebayashi","year":"2021","unstructured":"Yonebayashi S, Tajiri K, Hara M, Saito H, Suzuki N, Sakai S, Kimura T, Sato A, Sekimoto A, Fujita S. Generation of transgenic mice that conditionally overexpress tenascin-C. Front Immunol. 2021;12:620541.","journal-title":"Front Immunol"},{"issue":"4","key":"2780_CR59","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/antiox11040784","volume":"11","author":"B De Geest","year":"2022","unstructured":"De Geest B, Mishra M. Role of oxidative stress in diabetic cardiomyopathy. Antioxidants. 2022;11(4):784.","journal-title":"Antioxidants"},{"issue":"1","key":"2780_CR60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41572-024-00540-y","volume":"10","author":"CE Hamo","year":"2024","unstructured":"Hamo CE, DeJong C, Hartshorne-Evans N, Lund LH, Shah SJ, Solomon S, Lam CS. Heart failure with preserved ejection fraction. Nat Rev Dis Primers. 2024;10(1):55.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"2780_CR61","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cardfail.2020.08.010","volume":"26","author":"C Hage","year":"2020","unstructured":"Hage C, Svedlund S, Saraste A, Fax\u00e9n UL, Benson L, Fermer ML, Gan L-M, Shah SJ, Lam CS, Lund LH. Association of coronary microvascular dysfunction with heart failure hospitalizations and mortality in heart failure with preserved ejection fraction: a follow-up in the PROMIS-HFpEF study. J Cardiac Fail. 2020;26(11):1016\u201321.","journal-title":"J Cardiac Fail"},{"issue":"37","key":"2780_CR62","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","volume":"39","author":"SJ Shah","year":"2018","unstructured":"Shah SJ, Lam CS, Svedlund S, Saraste A, Hage C, Tan R-S, Beussink-Nelson L, Ljung Fax\u00e9n U, Fermer ML, Broberg MA. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J. 2018;39(37):3439\u201350.","journal-title":"Eur Heart J"},{"issue":"7","key":"2780_CR63","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/CS20130344","volume":"126","author":"VB Patel","year":"2014","unstructured":"Patel VB, Parajuli N, Oudit GY. Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications. Clin Sci. 2014;126(7):471\u201382.","journal-title":"Clin Sci"},{"issue":"5","key":"2780_CR64","first-page":"796","volume":"15","author":"DB Salvador Jr","year":"2022","unstructured":"Salvador DB Jr, Gamba MR, Gonzalez-Jaramillo N, Gonzalez-Jaramillo V, Raguindin PFN, Minder B, Gr\u00e4ni C, Wilhelm M, Stettler C, Doria A. Diabetes and myocardial fibrosis: a systematic review and meta-analysis. Cardiovasc Imaging. 2022;15(5):796\u2013808.","journal-title":"Cardiovasc Imaging"},{"issue":"3","key":"2780_CR65","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1681\/ASN.2016020165","volume":"28","author":"H Fu","year":"2017","unstructured":"Fu H, Tian Y, Zhou L, Zhou D, Tan RJ, Stolz DB, Liu Y. Tenascin-C is a major component of the fibrogenic niche in kidney fibrosis. J Am Soc Nephrol. 2017;28(3):785\u2013801.","journal-title":"J Am Soc Nephrol"},{"key":"2780_CR66","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fphys.2018.00382","volume":"9","author":"VF Segers","year":"2018","unstructured":"Segers VF, Brutsaert DL, De Keulenaer GW. Cardiac remodeling: endothelial cells have more to say than just NO. Front Physiol. 2018;9:382.","journal-title":"Front Physiol"},{"issue":"6","key":"2780_CR67","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1161\/01.RES.79.6.1131","volume":"79","author":"PL Jones","year":"1996","unstructured":"Jones PL, Rabinovitch M. Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ Res. 1996;79(6):1131\u201342.","journal-title":"Circ Res"},{"issue":"9","key":"2780_CR68","doi-asserted-by":"publisher","first-page":"C794","DOI":"10.1152\/ajpcell.00251.2013","volume":"306","author":"H Aguilar","year":"2014","unstructured":"Aguilar H, Fricovsky E, Ihm S, Schimke M, Maya-Ramos L, Aroonsakool N, Ceballos G, Dillmann W, Villarreal F, Ramirez-Sanchez I. Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis. Am J Physiol Cell Physiol. 2014;306(9):C794\u2013804.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"2780_CR69","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12933-024-02273-4","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang C, Shi Y, Liu C, Sudesh SM, Hu Z, Li P, Liu Q, Ma Y, Shi A, Cai H. Therapeutic strategies targeting mechanisms of macrophages in diabetic heart disease. Cardiovasc Diabetol. 2024;23(1):169.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2780_CR70","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s41467-017-01718-7","volume":"8","author":"L Zuliani-Alvarez","year":"2017","unstructured":"Zuliani-Alvarez L, Marzeda AM, Deligne C, Schwenzer A, McCann FE, Marsden BD, Piccinini AM, Midwood KS. Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers. Nat Commun. 2017;8(1):1595.","journal-title":"Nat Commun"},{"issue":"6","key":"2780_CR71","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.3390\/ijms21062128","volume":"21","author":"\u00c9 S\u00e1ghy","year":"2020","unstructured":"S\u00e1ghy \u00c9, V\u00f6r\u00f6s I, \u00c1gg B, Kiss B, Koncsos G, Varga ZV, G\u00f6rbe A, Giricz Z, Schulz R, Ferdinandy P. Cardiac miRNA expression and their mRNA targets in a rat model of prediabetes. Int J Mol Sci. 2020;21(6):2128.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2780_CR72","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1172\/JCI200524408","volume":"115","author":"FJ Giordano","year":"2005","unstructured":"Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Investig. 2005;115(3):500\u20138.","journal-title":"J Clin Investig"},{"issue":"2","key":"2780_CR73","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-13-0584","volume":"220","author":"S Guo","year":"2014","unstructured":"Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models to disease mechanisms. J Endocrinol. 2014;220(2):T1.","journal-title":"J Endocrinol"},{"issue":"5","key":"2780_CR74","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.yjmcc.2010.02.012","volume":"48","author":"M Kr\u00fcger","year":"2010","unstructured":"Kr\u00fcger M, Babicz K, von Frieling-Salewsky M, Linke WA. Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy. J Mol Cell Cardiol. 2010;48(5):910\u20136.","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"2780_CR75","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/01.RES.0000251056.85990.db","volume":"99","author":"P Oettgen","year":"2006","unstructured":"Oettgen P. Regulation of vascular inflammation and remodeling by ETS factors. Circ Res. 2006;99(11):1159\u201366.","journal-title":"Circ Res"},{"issue":"15","key":"2780_CR76","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1073\/pnas.1714102115","volume":"115","author":"J Nan","year":"2018","unstructured":"Nan J, Wang Y, Yang J, Stark GR. IRF9 and unphosphorylated STAT2 cooperate with NF-\u03baB to drive IL6 expression. Proc Natl Acad Sci. 2018;115(15):3906\u201311.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"2780_CR77","doi-asserted-by":"publisher","first-page":"165","DOI":"10.7707\/hmj.v5i2.140","volume":"5","author":"CH Frank","year":"2012","unstructured":"Frank CH, Muhammad AQ, Zahra H, Lina TAK, Dmytro I, Khatija P, Salem RKDY, Annie J, Murat O, Haider R. Ventricular myocyte contraction, intracellular calcium and expression of genes encoding cardiac muscle proteins in young and ageing Zucker diabetic fatty rat heart. Hamdan Med J. 2012;5(2):165\u201372.","journal-title":"Hamdan Med J"},{"issue":"1","key":"2780_CR78","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-024-02183-5","volume":"23","author":"YJ Tang","year":"2024","unstructured":"Tang YJ, Zhang Z, Yan T, Chen K, Xu GF, Xiong SQ, Wu DQ, Chen J, Jose PA, Zeng CY. Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53. Cardiovasc Diabetol. 2024;23(1):116.","journal-title":"Cardiovasc Diabetol"},{"key":"2780_CR79","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/cvr\/cvae210","volume":"120","author":"I Tuleta","year":"2024","unstructured":"Tuleta I, Hanna A, Humeres C, Aguilan JT, Sidoli S, Zhu F, Frangogiannis NG. Fibroblast-specific TGF-\u03b2 signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice. Cardiovasc Res. 2024;120:2047\u201363.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2780_CR80","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41419-017-0093-5","volume":"9","author":"J Gu","year":"2018","unstructured":"Gu J, Wang S, Guo H, Tan Y, Liang Y, Feng A, Liu Q, Damodaran C, Zhang Z, Keller BB. Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis. Cell Death Dis. 2018;9(2):82.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2780_CR81","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1161\/CIRCRESAHA.121.320324","volume":"133","author":"X Liu","year":"2023","unstructured":"Liu X, Burke RM, Lighthouse JK, Baker CD, Dirkx RA Jr, Kang B, Chakraborty Y, Mickelsen DM, Twardowski JJ, Mello SS. p53 Regulates the extent of fibroblast proliferation and fibrosis in left ventricle pressure overload. Circ Res. 2023;133(3):271\u201387.","journal-title":"Circ Res"},{"key":"2780_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2022.06.009","volume":"171","author":"B Chen","year":"2022","unstructured":"Chen B, Li R, Hernandez SC, Hanna A, Su K, Shinde AV, Frangogiannis NG. Differential effects of Smad2 and Smad3 in regulation of macrophage phenotype and function in the infarcted myocardium. J Mol Cell Cardiol. 2022;171:1\u201315.","journal-title":"J Mol Cell Cardiol"},{"key":"2780_CR83","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.yjmcc.2018.07.130","volume":"121","author":"LE Dorn","year":"2018","unstructured":"Dorn LE, Petrosino JM, Wright P, Accornero F. CTGF\/CCN2 is an autocrine regulator of cardiac fibrosis. J Mol Cell Cardiol. 2018;121:205\u201311.","journal-title":"J Mol Cell Cardiol"},{"key":"2780_CR84","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.yjmcc.2013.05.019","volume":"62","author":"T Tsoutsman","year":"2013","unstructured":"Tsoutsman T, Wang X, Garchow K, Riser B, Twigg S, Semsarian C. CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure. J Mol Cell Cardiol. 2013;62:164\u201378.","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"2780_CR85","doi-asserted-by":"publisher","first-page":"10184","DOI":"10.3390\/ijms241210184","volume":"24","author":"K Matsui","year":"2023","unstructured":"Matsui K, Torii S, Hara S, Maruyama K, Arai T, Imanaka-Yoshida K. Tenascin-C in tissue repair after myocardial infarction in humans. Int J Mol Sci. 2023;24(12):10184.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2780_CR86","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2310\/JIM.0b013e3182880c11","volume":"61","author":"B Sarli","year":"2013","unstructured":"Sarli B, Topsakal R, Kaya EG, Akpek M, Lam YY, Kaya MG. Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy. J Investig Med. 2013;61(4):728\u201332.","journal-title":"J Investig Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02780-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02780-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02780-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T11:02:52Z","timestamp":1748689372000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02780-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2780"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02780-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was approved by the regional Ethics Committee for Laboratory Animal Experiments at the Medical University of Vienna and the Austrian Ministry of Science Research and Economy (BMWFW- 66.009\/0014-V\/3b\/2018). All procedures conform to the guidelines from ARRIVE and Directive 2010\/63\/EU of the European Parliament on the protection of animals used for scientific purposes. The MetAnEnd study was conducted according to the International Conference on Harmonization and Good Clinical Practice guidelines and the Declaration of Helsinki. It was approved by the ethical review board at Karolinksa Institutet (Stockholm, Sweden). Written informed consent was obtained from all participants prior to study participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and agreed to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}